We are live on ! Find out more
CS

Credit Suisse Portfolio holdings

AUM $104B
1-Year Est. Return 34.76%
This Fund
S&P 500
This Quarter Est. Return
+10.76%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+395.52%
AUM
$138B
AUM Growth
+$19.4B
Cap. Flow
+$7.6B
Cap. Flow %
5.51%
Top 10 Hldgs %
15.42%
Holding
4,486
New
399
Increased
2,092
Reduced
1,353
Closed
351

Sector Composition

Rank Sector Weight
1 Healthcare 12.22%
2 Technology 11.9%
3 Financials 9.98%
4 Consumer Discretionary 7.32%
5 Communication Services 5.91%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
UBS icon
1326
CALL
UBS Group
UBS
$173B
$11.5M 0.01%
912,200
-2,382,252
-72% -$28.3M
CUZ icon
1327
Cousins Properties
CUZ
$5.19B
$11.4M 0.01%
277,808
-2,284
-0.8% -$89.8K
TWLO icon
1328
Twilio
TWLO
$30B
$11.4M 0.01%
116,352
-97,544
-46% -$9.96M
XOG
1329
DELISTED
Extraction Oil & Gas, Inc. Common Stock
XOG
$11.4M 0.01%
5,379,707
+4,975,770
+1,232% +$10.2M
WM icon
1330
CALL
Waste Management
WM
$90.6B
$11.4M 0.01%
99,900
PRI icon
1331
Primerica
PRI
$9.98B
$11.4M 0.01%
87,043
+35,755
+70% +$4.62M
MANH icon
1332
Manhattan Associates
MANH
$11.2B
$11.3M 0.01%
142,231
+54,688
+62% +$4.35M
RGLD icon
1333
Royal Gold
RGLD
$16.8B
$11.3M 0.01%
92,727
-9,142
-9% -$1.08M
ZM icon
1334
Zoom
ZM
$28.2B
$11.3M 0.01%
166,523
+144,455
+655% +$9.94M
DD icon
1335
PUT
DuPont de Nemours
DD
$18.5B
$11.3M 0.01%
139,875
+119,500
+587% +$9.92M
BPMC
1336
DELISTED
Blueprint Medicines
BPMC
$11.2M 0.01%
139,772
+101,758
+268% +$7.62M
OGE icon
1337
OGE Energy
OGE
$9.78B
$11.2M 0.01%
251,312
-72,131
-22% -$3.12M
PARA
1338
PUT
DELISTED
Paramount Global Class B
PARA
$11.2M 0.01%
+266,267
New +$10.3M
TWO
1339
Two Harbors Investment
TWO
$1.27B
$11.1M 0.01%
189,724
-22,360
-11% -$1.27M
ILMN icon
1340
CALL
Illumina
ILMN
$31B
$11.1M 0.01%
34,335
+3,803
+12% +$1.15M
NTES icon
1341
CALL
NetEase
NTES
$85.3B
$11.1M 0.01%
180,500
-8,000
-4% -$469K
EHC icon
1342
Encompass Health
EHC
$11B
$11.1M 0.01%
200,799
+74,351
+59% +$4.03M
BIO icon
1343
Bio-Rad Laboratories Class A
BIO
$8.71B
$11M 0.01%
29,789
-276
-0.9% -$97.3K
ALLY icon
1344
CALL
Ally Financial
ALLY
$13.2B
$11M 0.01%
+360,100
New +$11.2M
MEOH icon
1345
Methanex
MEOH
$4.3B
$11M 0.01%
284,471
+208,528
+275% +$7.82M
CEO
1346
DELISTED
CNOOC Limited
CEO
$11M 0.01%
65,898
-75,768
-53% -$11.6M
CIM
1347
Chimera Investment
CIM
$1.04B
$10.9M 0.01%
177,413
+21,287
+14% +$1.3M
OLED icon
1348
Universal Display
OLED
$3.68B
$10.9M 0.01%
52,974
-14,700
-22% -$2.78M
PRSP
1349
DELISTED
Perspecta Inc. Common Stock
PRSP
$10.9M 0.01%
412,848
+15,687
+4% +$418K
VHT icon
1350
Vanguard Health Care ETF
VHT
$18.1B
$10.9M 0.01%
56,646
-23,722
-30% -$4.25M

Similar funds

Credit Suisse's Q4 2019 Portfolio in Review

As of Q4 2019, Credit Suisse held 4,486 positions worth $138B, up 16% from $119B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Credit Suisse deployed $7.6B of net new capital in Q4 2019, opening 399 new positions and adding to 2,092 existing holdings. Its largest new stake was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 12% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was Vanguard Extended Market ETF, an estimated $566M trimmed.

  • Credit Suisse's largest Q4 2019 buy was iShares Russell 1000 Growth ETF: 1,727,952 shares worth $76M.
  • Credit Suisse added most to State Street SPDR S&P 500 ETF Trust in Q4 2019, an estimated $1.28B increase.
  • Credit Suisse's biggest Q4 2019 reduction was Vanguard Extended Market ETF, cutting an estimated $566M.
  • Credit Suisse fully exited Celgene Corp in Q4 2019, selling an estimated $685M.
  • Credit Suisse's ten largest holdings make up 15% of its $138B portfolio in Q4 2019.
  • Credit Suisse opened 399 new positions and closed 351 in Q4 2019.
  • Credit Suisse's portfolio value rose 16% quarter-over-quarter to $138B.

Based on Credit Suisse's 13F filing for Q4 2019, filed 12 Feb 2020.